198 related articles for article (PubMed ID: 16420967)
1. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
Yi H; Rong Y; Yankai Z; Wentao L; Hongxia Z; Jie W; Rongyue C; Taiming L; Jingjing L
Vaccine; 2006 Mar; 24(14):2575-84. PubMed ID: 16420967
[TBL] [Abstract][Full Text] [Related]
2. Ten tandem repeats of beta-hCG 109-118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
Yankai Z; Rong Y; Yi H; Wentao L; Rongyue C; Ming Y; Taiming L; Jingjing L; Jie W
Biochem Biophys Res Commun; 2006 Jul; 345(4):1365-71. PubMed ID: 16725110
[TBL] [Abstract][Full Text] [Related]
3. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
[TBL] [Abstract][Full Text] [Related]
4. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation.
Yoshida S; Tanaka T; Kita Y; Kuwayama S; Kanamaru N; Muraki Y; Hashimoto S; Inoue Y; Sakatani M; Kobayashi E; Kaneda Y; Okada M
Vaccine; 2006 Feb; 24(8):1191-204. PubMed ID: 16216394
[TBL] [Abstract][Full Text] [Related]
6. The fusion protein of HSP65 with tandem repeats of beta-hCG acting as a potent tumor vaccine in suppressing hepatocarcinoma.
Xiangbing H; Yankai Z; Ming L; Yong L; Yu Z; Huiyong Z; Yingying C; Jing H; Yun X; Liang J; Rongyue C; Jingjing L
Int Immunopharmacol; 2010 Feb; 10(2):230-8. PubMed ID: 19913113
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
9. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.
Moulton HM; Yoshihara PH; Mason DH; Iversen PL; Triozzi PL
Clin Cancer Res; 2002 Jul; 8(7):2044-51. PubMed ID: 12114402
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with the repeat β-hCG C-terminal peptide carried by heat shock protein-65 (HSP65) for inducing antitumor effects.
Yang J; Zhang Y; Wang H; Gao Z; Wang Z; Liu B; Zhang X; Du M; Huang X; Xu M; Wu J; Li T; Liu J; Cao R
Tumour Biol; 2012 Oct; 33(5):1777-84. PubMed ID: 22843331
[TBL] [Abstract][Full Text] [Related]
11. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis.
Lima KM; Santos SA; Lima VM; Coelho-Castelo AA; Rodrigues JM; Silva CL
Gene Ther; 2003 Apr; 10(8):678-85. PubMed ID: 12692596
[TBL] [Abstract][Full Text] [Related]
12. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
Sypniewska RK; Hoflack L; Tarango M; Gauntt S; Leal BZ; Reddick RL; Gravekamp C
Breast Cancer Res Treat; 2005 May; 91(1):19-28. PubMed ID: 15868428
[TBL] [Abstract][Full Text] [Related]
13. Inhibition effects on liver tumors of BALB/c mice bearing H22 cells by immunization with a recombinant immunogen of GnRH linked to heat shock protein 65.
Zhang Y; Xu J; Zhao R; Liu J; Wu J
Vaccine; 2007 Sep; 25(39-40):6911-21. PubMed ID: 17728021
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein.
Quintana FJ; Carmi P; Mor F; Cohen IR
Arthritis Rheum; 2004 Nov; 50(11):3712-20. PubMed ID: 15529360
[TBL] [Abstract][Full Text] [Related]
15. Enhanced immunogenicity of peptide P277 by heat shock protein HSP65 vector carrying tandem repeats of P277 to prevent type 1 diabetes in NOD mice.
Liang J; Aihua Z; Yu W; Jingjing L
Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):541-8. PubMed ID: 18473288
[TBL] [Abstract][Full Text] [Related]
16. A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo.
Guojun W; Wei G; Kedong O; Yi H; Yanfei X; Qingmei C; Yankai Z; Jie W; Hao F; Taiming L; Jingjing L; Rongyue C
Endocr Relat Cancer; 2008 Mar; 15(1):149-59. PubMed ID: 18310283
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with a potent DNA vaccine targeting B-cell epitopes of hGRP induces prophylactic and therapeutic antitumor activity in vivo.
Yong L; Huiyong Z; Jing H; Huaqian W; Xiangbing H; Yanjun M; Xiaoyu G; Li H; Yanan Y; Rongyue C; Hao F; Jingjing L; Jie W
Gene Ther; 2010 Apr; 17(4):459-68. PubMed ID: 20130655
[TBL] [Abstract][Full Text] [Related]
18. [Effect of the immune strategy based on BCG priming and Ag85A/GM-CSF DNA vaccine boosting in mice].
Tang Q; Dou J; Zhao FS; Chu LL; Pan M; Wang YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):591-4. PubMed ID: 17618574
[TBL] [Abstract][Full Text] [Related]
19. Vaccine adjuvant: it makes the difference.
Lima KM; dos Santos SA; Rodrigues JM; Silva CL
Vaccine; 2004 Jun; 22(19):2374-9. PubMed ID: 15193397
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]